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TheMHC class II I-E molecules in mice consist of two polypeptide chains (a
and ß) expressed as a dimer on the surface of cells . Strains of H-2b and H-23 haplo-
types do not express a surface I-E molecule because of a defect in the Ea gene (1,
2) . The Eß chain, however, is synthesized and can befound in the cytoplasm . Addi-
tionally, H-2f and H-2v mice have been shown to lack I-E expression because of
defective processing of both Ea and EßRNA (2, 3) . Only one recombinant, ATFR5
(I-A', Eâ), has been previously suggested to express a free E« chain on the cell sur-
face (4, 5) .
The intact I-E molecule is known to participate in response to both foreign an-
tigens and to self antigens . In the case of self antigens, the I-E-reactive Vß T cell
subsets of Vß11 and Vß17 are known to be deleted in I-E+ mice (6-8). In addition,
the I-E molecule plays a role in the deletion ofT cell subsets (Vß6, Vß8.1, Vß3) reac-
tive to the self antigen Mls-1a and Mls-2a (9-11) .
Previous studies had not indicated occurrence ofEaA0 dimers in vivo (5) . How-
ever, studies with transfectedL cells have demonstrated the necessity of a/ß dimers
for class II molecule expression (12, 13). Further studies have also shown that a low
frequency ofEgA0 dimers can be detected, especially in the absence of the Eß chains
(14) . In this report we examined recombinant mouse strains and transgenic mice
with defective Eß genes, but with normal Ea molecules . By flow cytometry, we found
low level expression in vivo of surface Eq molecule in B10.RFB2 (Aß, Aq, Eß, Eq)
and B10.RQB3 (A~, Aa, E~, Ek). We also found E« expression in H-2q mice with
the Ek transgene .
The Eo , molecule in these strains can enhance clonal deletion of two Vß TCR
expressingT cell subsets . TheVß11 T cells were deleted in theEa-expressingmice.
Vß6 T cells, which are deleted in Mls-1 amice and are also I-E regulated, were simi-
larly shown to be fewer in E«-expressing mice . In contrast, we found that only a
very weak MLR could be generated between the B10.RQB2 (Ea-) and B10.RQB3
(Ea+ ) cells . This combination also showed no signs of skin graft rejection .
Materials and Methods
Mice.
￿
Allmice were bred and maintained in ourmouse colony and theirH-2 genotypes
are shown in Table I . The B6-Eak transgenic mice were the kind gift of Drs . C. Benoist and
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TABLE I
Intensity of Antibody Binding in B10 Recombinant and Congenic Strain
Origin of recombinants is detailed in reference 24.
+ +, Bright; + -, dull; - -, no staining.
D. Mathis (INSERM, CNRS, Strasbourg, France). The Ek gene from this mouse was bred
into the B10.Q (H-2q) strain.
Flow Cytometry.
￿
The antibodies 14-4-4S and 17-3-3S (American Type Culture Collection,
Rockville, MD) were purified by protein A from culture supernatant and biotinylated. PBL
were isolated by Ficoll separation and stained with antibody at 4oC, followed by washing
and labeling with streptoavidin-phycoerythrin at 4oC. A FACS IV (Becton Dickinson & Co.,
Mountain View, CA) was used to analyze the cells. Lymphocytes were gated on, using light
scatter analysis, and resulting fluorescence is displayed on single fluorescence histograms.
The V011 antibody (RR3-15) and Vs6 antibody (44-22-1) were the kind gifts of Drs.
Kanagawa(Lilly Research Laboratories, LaJolla, CA) and Hengartner (Institute ofPathology,
University Hospital, Zurich, Switzerland). They were used as culture supernatants diluted
1 :1 with buffer and incubated at 4oC with PBL. Cells were washed and stained with FITC-
conjugated mouse anti-rat IgG (Accurate Chemical & Scientific Corp., Westbury NY). The
cells were then washed and labeled with biotinylated antiThy-1.2 (Becton Dickinson & Co.)
followed by streptavidin-phycoerythrin (Tago Inc., Burlingame, CA). The FACS IV (Becton
Dickinson & Co.) was again used and fluorescence intensities are displayed as dual-color
counters. All dilutions and washes were done in PBS with 1% BSA (Sigma Chemical Co.,
St. Louis, MO) and 0.05% sodium azide.
MLC and Skin Grafts.
￿
3 x 105 lymph node cells (LNC) were cultured with irradiated
stimulator spleen cells as described earlier (15). Meansand SEM were calculated from tripli-
cate cultures.
Skin grafts were performed as described earilier (16). Briefly, tail skin from B10.RQB3 was
grafted on the back of B10.RQB2 mice, and observed daily for signs of rejection.
Results
Ea Expression.
￿
The Ea-specific mAb 14-4-4S (17) stained B10X PBL brightly.
B10.M showed no labeling, while the recombinant strain B10.RFB2 with a nonex-
pressed Ef and a functional Ek showed low level E« expression (Fig. 1 A). Strain
B10.RFP with a functional E« also had similar levels of E« expression. Strain
B10.RQB2 (E«- ) showed no labeling, while B10 .RQB3 (Eq) gave low level of Ea ex-
pression (Fig. 1 B). Both of these strains have nonfunctional E~ chains, and differ
only at the E« gene. The B10.Q;Ea transgenic mice confirmed these results. Fig. 1
C shows low level expression in the B10 .-E . transgenic mice as compared with
B10X and a B10.QE« - sibling.
E0 Expression.
￿
Because the recombination in these mice lies within the E0 gene
(18), we checked for the possibility of low levels of ES being expressed with the E«
Strain K A0
H-2
Aa
Molecules
E0 Ea D
Intensity
of
14-4-4
labeling`
17-3-3
B10X k k k k k k ++ ++
B10.M f f f f f f -- --
B10.RFB2 f f f f k b + - - -
BIO.RFB3 f f f f p b + - - -
BIO.RQB2 q q q q q b - - - -
B10.RQB3 q q q q k b + - - -
B10.RFP f f f f p r + - - -E
c
m
U
ANDERSON AND DAVID
￿
BRIEF DEFINITIVE REPORT
￿
1005
B10X
B10.RFB2
B10.K
B10.RQB2
B10.RQB3
B10.K
B10.Q-Ea-
10 100 1,000 1
￿
10 100 1,000 1
￿
10 100 1,000 1
￿
10 100 1,000
Relative fluorescence
￿
Relative fluorescence
￿
Relative fluorescence
￿
Relative fluorescence
144-4
￿
14-44
￿
1444
￿
17-3-3
FIGURE 1.
￿
Expression of Ea and Eo molecules labeled with 14-4-4 (En) and 17-3-3 (Ef). (A)
H-2r recombinants; (B) H-24 recombinants; (C) Ea transgenics; (D) ES expression in recom-
binants.
molecule. PBLs were labeled with the E,o-specific antibody 17-3-3S (17). Fig. 1 D
shows 17-3-3 staining of B10X, but no detectable expression of ES was seen in
B10.RFB2 or B10.RQB3. Table I summarizes the E« and E0 screening results.
Clonal Deletion of TCR Vs11 ` TCells.
￿
The percent of TCR V011 + T cells in the
blood is shown in Table II. Bill et al. (6) have shown that the I-E molecule is neces-
sary in the deletion of V011 + T cells. In B10.RFB2 the low level of Ea expression
decreases the percentage of VS11 + T cells to -25% of that found in B10.M. Simi-
larly, Ea+ B10.RQB3 shows approximatelyhalfthe level of Vg11 + T cells compared
with Ea- B10.RQB2. B10.Q;Ea+ transgenic mice also had consistently lower levels
of V011 cells while the Ea- full siblings were similar to the B10.Q parent.
Clonal Deletion of TCR VS6+ TCells.
￿
TCRV06+ cells are clonally deleted in the con-
text of Hs-la and I-A and/or I-E molecules. Fl crosses were made between DBA/1
(Mls-la, I-E-) and strains of mice listed in Table 11. DBA/1 (H-24) was chosen because
TABLE II
Level of V,B T Cell Expression
B10X
B10.RFB2
" + +, Bright; + -, dull; - -, no staining.
t Mean percent ± SEM of peripheral blood Tcell labeled with V,6 antibody.
n ;?t 3 from individual mice.
Strain
Ea
Expression" Percent Vol1:
Percent Vg6 in
DBA/l F1 crossl
B10X ++ 0.5 t 0 0.3 t 0.1
B10.M - - 4.0 0.1 2.4 1 0.1
B10.RFB2 + - 0.9 1 0.1 0.6 1 0
B10.RQB2 - - 6.5 1 0.3 4.9 1 0.1
Bl0.RQB3 + - 2.9 1 0.2 1.7 1 0.1
BIO.QE« +- 4.4 ± 0.1 2.3 1 0.2
B10.QEq - - 6.8 ± 0.1 4.7 t 0.31006
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it is I-E- and previously shown to have littleinfluence onthe donal deletion ofTcells
reactive to Mis-la (19). (DBA/1 x B10.RFB2)FZ expresses x+25% ofthe level ofVß6+
T cells compared with (DBA/1 x B10.M)Fl (Table II). (DBA/1 x B10.RQB3)Fi
showed <50% of the Vß6+ cells found in (DBA/1 x B10.RQB2)Fi mice. (B10.Q
Ea' x DBA/1)Fl mice also deleted 50% of Vß6+ T cells compared with (B10.Q- Ea- x DBA/1)Fl mice.
EaMolecule Isa WeakAlloantigm
￿
B10.RQB2 (E(x-) LNC respondedwell in an MLR
to MHC differences (B10.K) but no significant response was seen against B10.RQB3
(Ea+) from the grafted or ungrafted mice (p > 0.01, data not shown). B10.RQB3 tail
skin, although rejected in 10-14 d when grafted onto B10X, was not rejected when
grafted onto three B10.RQB2 mice after 50 d.
Discussion
FACS analysis has shown in vivo expression ofthe Ea molecule on the cell surface
in I-Aa and I-Af recombinant mouse strains that do not express Eß. The possibility
oflow levels oftranscribed Eß carrying Eato thecellsurface was discounted by demon-
strating the lack ofbinding of an Eß-specific antibody (17-3-3) in these strains. The
observation that Ea is expressed in transgenic mice also confirms that Eß is not re-
quired forthe Easurface expression. Since Eachain cannot be expressed on the mem-
brane by itself, it must be pairing with the
surface expression. The existence of an Ea + Aß hybrid molecule has recently been
shown in a BALB/clymphoma (20). We were not able to pick up this hybrid molecule
by immunoprecipitation. The low level of expression is presumably due to the very
low affinity binding ofEa and Aß as comparedwith Aabindingto Aß. Previous studies
showing Ea chain expression have also acknowledged the possibility of low affinity
binding, which prevents precipitation of the A0 chain with Ea in vivo (5, 15). This
hybrid molecule hasnot so farbeen detected invivo inmice expressing Eß. The excess
cytoplasmic Ea chain in strains lacking Eß mayincrease the association ofEawithAß.
Our results confirm in vivo previous studies done in vitro with transfected L cells and
in B cell lymphomas.
The Ea + Aß hybrid molecule does function in vivo in
cells expressing Vß6 and Vß11 TCRs. Both of these TCRs have been shown to re-
quirethe involvementofthe I-Emolecule, inpresentation ofselfantigensor in recogni-
tion ofthe I-E molecule. We have shown the Ea chain is significant in these processes.
The expression ofEa, however, does not lead to strong allorecognition in stimu-
lating an MLR or in graft rejection. Previous studies have shown differences at the
intact I-Emolecule tobeweakly antigenic inallograft rejection(21, 22)andtostimulate
a moderate MLR (15). The lower Ea expression in these recombinant mice com-
pared with other I-E* strains might lead to the limited response. However, this
seems unlikely since LPS-stimulated spleen cells with increased Ea expression are
still not effective in stimulating a strong primary MLR (data not shown). The al-
lorecognitionagainst anintact I-E molecule maybepredominantlydirected against
the polymorphic Ea molecule while theEamolecule shows a great deal ofhomology
between various haplotypes (23). It is possible that the respondermice we used are
tolerant to the Ea molecule or theTcells with highly I-E-reactive TCRs are missing,
such as Vß17 (7). It will be interesting to see whether we can generate E"'-specific
antibodies in this strain combination.ANDERSON AND DAVID
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In conclusion, we have shown that the Ea molecules can be expressed in vivo as
a hybrid Ec Ao dimer and function in the thymus by clonally deleting T cells but
cannot be recognized as an alloantigen in graft rejection. Studies are currently un-
derway to see whether this hybrid molecule plays a role in immune tolerance and
evation of tumor destruction.
Summary
We have found cell surface expression of an Eq molecule in recombinant and trans-
genic mouse strains lacking an Eg molecule. Flow cytometry has shown low level
expression of Ea in B10.RQB3 (I-AqE«) and B10.RFB2 (I-AfE.Y) mice. We have also
found that B10.Q (H-2q) mice can express the E« transgene. Since these strains do
not have functional E0 chains, we propose that the E,A0 hybrid dimers are formed
in low numbers and can be picked up by FAGS analysis. So far we have not been
able to identify these hybrid molecules by cytotoxicity or immunoprecipitation. The
Ec ,/A# molecule can function in vivo during thymic selection in the clonal deletion
of two VS TCR subsets, VS11 and VS6, which have been shown to interact with
the intact I-E molecule.
We thank Dr. Benoist for the E,,, transgennc mice and Drs. Kanagawa, Palmer, and Hen-
gartner for the Voll and V06 TCR antibodies. We also thank Julie Hansen for expert mouse
husbandry; Suresh Savarirayan for generating the recombinant mice; and Mary Brandt for
skillful preparation of the manuscript.
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